Home » News » Drug Sponsors » Gilead Alberta expands research and manufacturing facility in Canada

Gilead Alberta expands research and manufacturing facility in Canada

Wednesday, October 30, 2013

Gilead Alberta, a fully integrated research and manufacturing facility of Gilead Sciences Canada, has announced a $47 million expansion of its research and manufacturing facility in Edmonton, Alberta. The expansion will create more than 80 full-time positions at Gilead Alberta and increase the size of the facility by 45,000 square feet to create new laboratory and research space. 

The Edmonton site develops and manufactures Gilead’s investigational medicines for clinical research programs in hepatitis C, HIV/AIDS and cancer. In 2012, the company spent almost $55 million dollars in R&D in Canada, and most of this investment was targeted to Alberta. There currently are more than 250 staff working at the Edmonton site in R&D, analytical research, drug manufacturing and quality assurance. 

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!